摘要
目的分析在为骨质疏松症患者实施治疗的过程中联合运用仙灵骨葆胶囊与阿法骨化醇软胶囊所获得的临床疗效。方法此研究将在天津市北辰区中医院接受骨质疏松症治疗的患者86例作为实验对象,根据随机数字表法将患者分为人数相同的研究组(例数:43例,治疗药物:阿法骨化醇软胶囊+仙灵骨葆胶囊)与对比组(例数:43例,治疗药物:阿法骨化醇软胶囊)。结果研究组患者治疗效果、治疗后骨密度、骨源性碱性磷酸酶、骨钙素水平、血清钙、血清磷和疼痛评分均与对比组患者存在显著差异,P<0.05。两组患者治疗前骨密度、骨源性碱性磷酸酶、骨钙素水平、血清钙、血清磷和疼痛评分无明显差异,P>0.05。结论仙灵骨葆胶囊联合阿法骨化醇软胶囊是骨质疏松症患者的理想治疗方案。
Objective To analyze the clinical effect Xianling Gubao capsule combined with alfacalcidol soft capsule in the treatment of osteoporosis.Methods 86 patients with osteoporosis in our hospital were included in this study,according to the random number table,the patients were divided into the same number of patients in the study group(43 cases,treated with AFA and Xianlinggubao capsules)and the control group(43 cases,treated with AFA).Results There were significant differences between the study group and the control group in therapeutic effect,bone mineral density,bone Alkaline phosphatase,osteocalcin levels,serum calcium,serum phosphorus and pain scores,P<0.05.There were no significant differences in the incidence of adverse reactions,BMD,bone Alkaline phosphatase,osteocalcin levels,serum calcium,serum phosphorus and pain scores between the two groups before treatment(P>0.05).Conclusion Xianling Gubao capsule combined with alpha-ossifying alcohol soft capsule is an ideal treatment for osteoporosis.
作者
李逸仙
Li Yixian(Tianjin Beichen District Hospital of Traditional Chinese Medicine,Tianjin 300400,China)
出处
《首都食品与医药》
2023年第5期134-136,共3页
Capital Food Medicine
关键词
仙灵骨葆胶囊
阿法骨化醇软胶囊
骨质疏松症
骨密度
骨代谢生化指标
Xianling Gubao capsule
AFA Guhua Chun Soft capsule
osteoporosis
bone mineral density
biochemical markers of bone metabolism
